Financhill
Buy
59

HLMN Quote, Financials, Valuation and Earnings

Last price:
$9.94
Seasonality move :
10.11%
Day range:
$9.82 - $10.18
52-week range:
$8.43 - $12.08
Dividend yield:
0%
P/E ratio:
248.38x
P/S ratio:
1.33x
P/B ratio:
1.65x
Volume:
4.7M
Avg. volume:
921.6K
1-year change:
14.2%
Market cap:
$2B
Revenue:
$1.5B
EPS (TTM):
$0.04
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $1.2B $1.4B $1.4B $1.5B $1.5B
Revenue Growth (YoY) -- 12.68% 4.22% 4.23% -0.66%
 
Cost of Revenues $693.9M $781.8M $859.6M $846.6M $829M
Gross Profit $520.5M $586.5M $566.4M $639.8M $647.5M
Gross Profit Margin 42.86% 42.86% 39.72% 43.04% 43.86%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $382.7M $398.5M $437.9M $481M $452.1M
Other Inc / (Exp) -$2.2M -$223K $8.6M -- --
Operating Expenses $512.8M $520.7M $556.1M $599.9M $586.6M
Operating Income $7.7M $65.8M $10.3M $39.9M $60.9M
 
Net Interest Expenses $114.2M $99.5M $69M $54.6M $68.3M
EBT. Incl. Unusual Items -$108.8M -$33.9M -$50.1M -$14.7M -$7.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$23.3M -$9.4M -$11.8M $1.8M $2.2M
Net Income to Company -$85.5M -$24.5M -$38.3M -$16.4M -$9.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$85.5M -$24.5M -$38.3M -$16.4M -$9.6M
 
Basic EPS (Cont. Ops) -$0.46 -$0.13 -$0.28 -$0.08 -$0.05
Diluted EPS (Cont. Ops) -$0.46 -$0.13 -$0.28 -$0.08 -$0.05
Weighted Average Basic Share $187.6M $187.6M $134.7M $194.2M $194.7M
Weighted Average Diluted Share $187.6M $187.6M $134.7M $194.2M $194.7M
 
EBITDA $130M $192.5M $139.6M $159.9M $182.6M
EBIT $5.5M $65.5M $18.9M $39.9M $60.9M
 
Revenue (Reported) $1.2B $1.4B $1.4B $1.5B $1.5B
Operating Income (Reported) $7.7M $65.8M $10.3M $39.9M $60.9M
Operating Income (Adjusted) $5.5M $65.5M $18.9M $39.9M $60.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $398.7M $364.5M $378.5M $398.9M $393.3M
Revenue Growth (YoY) -- -8.58% 3.86% 5.39% -1.42%
 
Cost of Revenues $227.5M $237M $214.8M $222.6M $203.7M
Gross Profit $171.2M $127.5M $163.7M $176.3M $189.6M
Gross Profit Margin 42.94% 34.98% 43.26% 44.19% 48.21%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $107.5M $110.5M $133.2M $113.4M $130.3M
Other Inc / (Exp) $867K -$3.7M -- -- --
Operating Expenses $136.1M $140.8M $164.2M $141.6M $162.7M
Operating Income $35.1M -$13.3M -$449K $34.7M $26.9M
 
Net Interest Expenses $23.9M $21.3M $14.7M $16.7M $15.1M
EBT. Incl. Unusual Items $12.1M -$38.3M -$15.1M $18M $11.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.8M -$5.8M -$5.7M $13M $4.4M
Net Income to Company -- -$32.5M -$9.5M $5.1M $7.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $9.3M -$32.5M -$9.5M $5.1M $7.4M
 
Basic EPS (Cont. Ops) $0.05 -$0.19 -$0.05 $0.03 $0.04
Diluted EPS (Cont. Ops) $0.05 -$0.19 -$0.05 $0.03 $0.04
Weighted Average Basic Share $187.6M $168.4M $194.4M $194.8M $196.3M
Weighted Average Diluted Share $187.6M $168.4M $194.4M $196.6M $199M
 
EBITDA $66.8M $4.9M $29.4M $64.8M $60.2M
EBIT $36M -$25.1M -$449K $34.7M $26.9M
 
Revenue (Reported) $398.7M $364.5M $378.5M $398.9M $393.3M
Operating Income (Reported) $35.1M -$13.3M -$449K $34.7M $26.9M
Operating Income (Adjusted) $36M -$25.1M -$449K $34.7M $26.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $1.4B $1.5B $1.5B $1.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $845.8M $853.5M $842M $767.1M
Gross Profit -- $562.8M $626.6M $637.4M $703.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $431.5M $478.3M $450.9M $486.2M
Other Inc / (Exp) $867K -$1.4M $10.7M -- -$3M
Operating Expenses -- $550.3M $592.1M $577M $624.6M
Operating Income -- $12.5M $34.5M $60.3M $79.1M
 
Net Interest Expenses $23.9M $88M $42M $68.6M $59.7M
EBT. Incl. Unusual Items -- -$76.9M $3.1M -$8.2M $16.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$18.1M -$908K $5.2M $7.9M
Net Income to Company -- -- $4M -$13.4M $8.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$58.8M $4M -$13.4M $8.4M
 
Basic EPS (Cont. Ops) -- -$0.33 $0.02 -$0.07 $0.04
Diluted EPS (Cont. Ops) -- -$0.33 $0.01 -$0.07 $0.04
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $126.5M $170.4M $183.6M $202.5M
EBIT -- $3M $53.2M $60.3M $76.1M
 
Revenue (Reported) -- $1.4B $1.5B $1.5B $1.5B
Operating Income (Reported) -- $12.5M $34.5M $60.3M $79.1M
Operating Income (Adjusted) -- $3M $53.2M $60.3M $76.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $398.7M $1.1B $1.1B $1.1B $1.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $227.5M $654.3M $648.2M $643.7M $581.8M
Gross Profit $171.2M $427.2M $487.4M $485M $541.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $107.5M $325.6M $366M $335.9M $370M
Other Inc / (Exp) $867K -$2.1M -- -- -$3M
Operating Expenses $136.1M $415.2M $451.3M $428.4M $466.4M
Operating Income $35.1M $12M $36.2M $56.6M $74.8M
 
Net Interest Expenses $23.9M $65.8M $38.9M $52.9M $44.3M
EBT. Incl. Unusual Items $12.1M -$55.9M -$2.7M $3.7M $27.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.8M -$11M -$147K $3.3M $9M
Net Income to Company -- -$44.9M -$2.5M $470K $18.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $9.3M -$44.9M -$2.5M $470K $18.5M
 
Basic EPS (Cont. Ops) $0.05 -$0.26 -$0.01 -- $0.09
Diluted EPS (Cont. Ops) $0.05 -$0.26 -$0.02 -- $0.09
Weighted Average Basic Share $375.1M $543.6M $582.5M $584M $587.7M
Weighted Average Diluted Share $375.1M $543.6M $585.1M $586.7M $592.8M
 
EBITDA $66.8M $93.7M $124.6M $148.3M $168.2M
EBIT $36M $1.9M $36.2M $56.6M $71.8M
 
Revenue (Reported) $398.7M $1.1B $1.1B $1.1B $1.1B
Operating Income (Reported) $35.1M $12M $36.2M $56.6M $74.8M
Operating Income (Adjusted) $36M $1.9M $36.2M $56.6M $71.8M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- $21.5M $14.6M $31.1M $38.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $121.2M $107.2M $87M $103.5M
Inventory -- $391.7M $533.5M $489.3M $382.7M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $19.3M $13M $24.2M $23.2M
Total Current Assets -- $553.7M $668.3M $631.6M $548M
 
Property Plant And Equipment -- $259.5M $256.6M $257.2M $288M
Long-Term Investments -- -- -- -- --
Goodwill -- $816.2M $825.4M $823.8M $825M
Other Intangibles -- $826M $794.7M $734.5M $655.3M
Other Long-Term Assets -- $11.2M $16.6M $23.6M $14.8M
Total Assets -- $2.5B $2.6B $2.5B $2.3B
 
Accounts Payable -- $201.5M $186.1M $131.8M $140.3M
Accrued Expenses -- $80.8M $61.8M $55.5M $52M
Current Portion Of Long-Term Debt -- $11.5M $11.4M $10.6M $10M
Current Portion Of Capital Lease Obligations -- $12.2M $13.1M $12.3M $14.4M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $311.9M $277.3M $215.4M $223.1M
 
Long-Term Debt -- $1.5B $906.5M $884.6M $731.7M
Capital Leases -- -- -- -- --
Total Liabilities -- $2.1B $1.4B $1.3B $1.2B
 
Common Stock -- $9K $20K $20K $20K
Other Common Equity Adj -- -$29.4M -$27.2M -$21M -$27.8M
Common Equity -- $364.6M $1.2B $1.2B $1.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $364.6M $1.2B $1.2B $1.2B
 
Total Liabilities and Equity -- $2.5B $2.6B $2.5B $2.3B
Cash and Short Terms -- $21.5M $14.6M $31.1M $38.6M
Total Debt -- $1.5B $917.9M $895.2M $741.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $14.4M $29.2M $39.3M $59.8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $139.7M $126.1M $129.7M $129.6M
Inventory -- $506.4M $535M $397.1M $419.4M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $15.6M $25.9M $29.8M $15.6M
Total Current Assets -- $676.1M $716.2M $595.8M $624.4M
 
Property Plant And Equipment -- $258M $259.5M $288.7M $307M
Long-Term Investments -- -- -- -- --
Goodwill -- $826M $823.6M $824.3M $829.2M
Other Intangibles -- $810.6M $749.1M $688.5M $622.6M
Other Long-Term Assets -- $14.3M $26.7M $14.6M $14.3M
Total Assets -- $2.6B $2.6B $2.4B $2.4B
 
Accounts Payable -- $219.4M $150.6M $159.3M $165.8M
Accrued Expenses -- $59.3M $88.8M $43.8M $66.2M
Current Portion Of Long-Term Debt -- $7.2M $12.8M $10.7M $13M
Current Portion Of Capital Lease Obligations -- $12.7M $12.9M $13.8M $16.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $302.8M $268.8M $233.5M $269.1M
 
Long-Term Debt -- $890.6M $913.8M $780M $730.7M
Capital Leases -- -- -- -- --
Total Liabilities -- $1.5B $1.4B $1.3B $1.2B
 
Common Stock -- $19K $20K $20K $20K
Other Common Equity Adj -- -$27.6M -$20.6M -$29.3M -$39.1M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $1.1B $1.2B $1.2B $1.2B
 
Total Liabilities and Equity -- $2.6B $2.6B $2.4B $2.4B
Cash and Short Terms -- $14.4M $29.2M $39.3M $59.8M
Total Debt -- $897.8M $926.6M $790.7M $743.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$85.5M -$24.5M -$38.3M -$16.4M -$9.6M
Depreciation & Amoritzation $124.6M $126.9M $120.7M $120M $121.6M
Stock-Based Compensation $3M $5.1M $15.3M $13.5M $12M
Change in Accounts Receivable $22.9M -$32.4M $15.1M $19.9M -$15.9M
Change in Inventories -$3.2M -$67.1M -$137.8M $38.8M $103.7M
Cash From Operations $52.4M $92.1M -$110.3M $119M $238M
 
Capital Expenditures $57.8M $45.3M $51.6M $69.6M $65.8M
Cash Acquisitions -$6.1M -$800K -$38.9M -$2.5M -$1.7M
Cash From Investing -$53.5M -$46.1M -$90.5M -$72.8M -$67.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $43.5M $99M $1.2B $244M $178M
Long-Term Debt Repaid -$50M -$151.4M -$1.8B -$277.1M -$340.9M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$662K -- $434.2M $1.8M -$1.2M
Cash From Financing -$7.1M -$45.1M $193.3M -$28.7M -$162M
 
Beginning Cash (CF) $28.2M $20M $21.5M $14.6M $31.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$8.2M $902K -$7.4M $17.5M $8.2M
Ending Cash (CF) $20M $21.5M $14.6M $31.1M $38.6M
 
Levered Free Cash Flow -$5.4M $46.8M -$161.8M $49.4M $172.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -$32.5M -$9.5M $5.1M $7.4M
Depreciation & Amoritzation -- $30M $29.9M $30M $33.3M
Stock-Based Compensation -- $5.3M $2.5M $3.1M $3.3M
Change in Accounts Receivable -- $6.5M $5.7M $575K $5.5M
Change in Inventories -- -$37M $37M $30.6M $8.9M
Cash From Operations -- -$45.5M $48.5M $56.4M $63.7M
 
Capital Expenditures -- $14.3M $17.5M $15.1M $24.1M
Cash Acquisitions -- -- -- -- -$34M
Cash From Investing -- -$14.3M -$17.5M -$15.2M -$58.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $966.9M $40M $114M $12M
Long-Term Debt Repaid -- -$1.7B -$59.6M -$157.8M -$12.9M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $435.2M $1.3M $988K -$736K
Cash From Financing -- $57.7M -$17.5M -$41.8M $883K
 
Beginning Cash (CF) -- $16.3M $17.7M $37.7M $54M
Foreign Exchange Rate Adjustment -- $220K -$1.9M $2.2M -$635K
Additions / Reductions -- -$2M $13.4M -$577K $6.4M
Ending Cash (CF) -- $14.4M $29.2M $39.3M $59.8M
 
Levered Free Cash Flow -- -$59.7M $30.9M $41.3M $39.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $4M -$13.4M $8.4M
Depreciation & Amoritzation -- -- $117.2M $123.3M $126.4M
Stock-Based Compensation -- $8.8M $17.2M $11.8M $12.6M
Change in Accounts Receivable -- -- $12.8M -$3.5M $4.1M
Change in Inventories -- -- -$33.8M $137.7M $8.8M
Cash From Operations -- -$38.8M $58.3M $227.3M $206.7M
 
Capital Expenditures -- $37M $61M $75.3M $77.8M
Cash Acquisitions -- -$39.1M -$2.3M -$300K -$59.2M
Cash From Investing -- -- -$63.3M -$76.7M -$137.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $237M $255M $83M
Long-Term Debt Repaid -- -- -$218.6M -$400.8M -$139.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $273K $1.2M -$1.3M
Cash From Financing -- -- $21.4M -$142.3M -$48.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $16.4M $8.3M $20.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -$2.7M $152M $128.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -$44.9M -$2.5M $470K $18.5M
Depreciation & Amoritzation -- $91.9M $88.4M $91.7M $96.4M
Stock-Based Compensation -- $8.8M $10.8M $9.1M $9.7M
Change in Accounts Receivable -- -$17.1M -$19.5M -$42.9M -$22.9M
Change in Inventories -- -$110.1M -$6M $92.8M -$2M
Cash From Operations -- -$105.3M $63.2M $171.5M $140.2M
 
Capital Expenditures -- $37M $46.4M $52.1M $64.2M
Cash Acquisitions -- -$39.1M -$2.5M -$300K -$57.8M
Cash From Investing -- -$76.1M -$48.9M -$52.8M -$122.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1.1B $161M $172M $77M
Long-Term Debt Repaid -- -$1.8B -$161.4M -$285.1M -$84M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $434.2M $273K -$292K -$332K
Cash From Financing -- $173.7M $1.8M -$111.8M $1.7M
 
Beginning Cash (CF) -- $51.7M $51.7M $103.5M $123.2M
Foreign Exchange Rate Adjustment -- $610K -$1.5M $1.2M $1.6M
Additions / Reductions -- -$7.7M $16.1M $7M $19.7M
Ending Cash (CF) -- $44.6M $66.3M $111.7M $144.5M
 
Levered Free Cash Flow -- -$142.3M $16.8M $119.3M $76M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock